AngioDynamics to Present at the 2017 Canaccord Genuity Growth Conference
August 07 2017 - 7:49AM
AngioDynamics (NASDAQ:ANGO), a leading provider of innovative,
minimally invasive medical devices for vascular access, surgery,
peripheral vascular disease and oncology, announced today that
Michael Greiner, Executive Vice President and Chief Financial
Officer, is scheduled to present and participate in a fireside chat
at the Canaccord Genuity Growth Conference on Thursday, August 10,
2017, at 11:00 a.m. ET. The conference will be held at the
InterContinental in Boston, MA.
A live audio and/or webcast and subsequent
archived replay of AngioDynamics’ presentation may be accessed via
the investor relations section of the Company’s website under
“Events & Presentations” at
http://investors.angiodynamics.com/events.cfm. The replay will be
available for 90 days after the event.
About AngioDynamics
AngioDynamics Inc. is a leading provider of innovative, minimally
invasive medical devices used by professional healthcare providers
for vascular access, surgery, peripheral vascular disease and
oncology. AngioDynamics’ diverse product lines include
market-leading ablation systems, fluid management systems, vascular
access products, angiographic products and accessories, drainage
products, thrombolytic products and venous products. More
information is available at www.AngioDynamics.com.
TrademarksAngioDynamics and the
AngioDynamics logo are trademarks and/or registered trademarks of
AngioDynamics Inc., an affiliate or a subsidiary.
Contact Information:
Caitlin Stefanik
AngioDynamics
cstefanik@angiodynamics.com
518-795-1418
AngioDynamics (NASDAQ:ANGO)
Historical Stock Chart
From Aug 2024 to Sep 2024
AngioDynamics (NASDAQ:ANGO)
Historical Stock Chart
From Sep 2023 to Sep 2024